PharMerica Corp. Company Profile (NYSE:PMC)

About PharMerica Corp.

PharMerica Corp. logoPharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Stores
  • Sub-Industry: Health Care Distributors
  • Exchange: NYSE
  • Symbol: PMC
  • CUSIP: 71714F10
Key Metrics:
  • Previous Close: $25.89
  • 50 Day Moving Average: $25.01
  • 200 Day Moving Average: $24.58
  • 52-Week Range: $19.79 - $35.81
  • Trailing P/E Ratio: 26.75
  • Foreward P/E Ratio: 11.46
  • P/E Growth: 1.79
  • Market Cap: $796.48M
  • Outstanding Shares: 30,764,000
  • Beta: 0.68
Additional Links:
Companies Related to PharMerica Corp.:

Analyst Ratings

Consensus Ratings for PharMerica Corp. (NYSE:PMC) (?)
Ratings Breakdown: 1 Sell Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $31.83 (22.96% upside)

Analysts' Ratings History for PharMerica Corp. (NYSE:PMC)
Show:
DateFirmActionRatingPrice TargetDetails
6/7/2016Bank of America Corp.Initiated CoverageBuy$32.00View Rating Details
5/10/2016Barrington ResearchReiterated RatingOutperform$30.00 -> $34.00View Rating Details
3/15/2016Credit Suisse Group AGInitiated CoverageOutperform$30.00View Rating Details
2/29/2016KeyCorpLower Price TargetOverweight$39.00 -> $32.00View Rating Details
2/29/2016Barclays PLCLower Price TargetUnderweight$27.00 -> $22.00View Rating Details
12/30/2015Cowen and CompanyReiterated RatingBuy$39.00 -> $41.00View Rating Details
9/11/2014Goldman Sachs Group Inc.Initiated CoverageNeutral$29.00View Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for PharMerica Corp. (NYSE:PMC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016        
8/9/2016Q216$0.47$0.47$508.31 million$519.60 millionViewListenView Earnings Details
5/6/2016Q116$0.43$0.45$509.45 million$524.50 millionViewListenView Earnings Details
2/26/2016Q415$0.41$0.45$506.40 million$520.60 millionViewListenView Earnings Details
11/6/2015Q315$0.36$0.39$480.35 million$498.80 millionViewListenView Earnings Details
8/7/2015Q215$0.33$0.37$491.66 million$497.50 millionViewListenView Earnings Details
5/7/2015Q115$0.43$0.48$500.95 million$511.60 millionViewListenView Earnings Details
3/2/2015Q414$0.43$0.45$491.99 million$523.50 millionViewListenView Earnings Details
11/6/2014Q314$0.40$0.45$439.63 million$470.20 millionViewListenView Earnings Details
8/5/2014Q214$0.36$0.40$432.70 million$448.60 millionViewListenView Earnings Details
5/1/2014Q114$0.33$0.37$417.76 million$452.20 millionViewListenView Earnings Details
2/28/2014Q413$0.38$0.44$421.16 million$433.20 millionViewListenView Earnings Details
11/5/2013Q313$0.32$0.49$398.02 million$442.00 millionViewListenView Earnings Details
8/2/2013Q2 2013$0.34$0.44$414.15 million$458.50 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.34$0.46$435.10 million$439.80 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.29$0.12$432.43 million$433.20 millionViewListenView Earnings Details
11/1/2012Q312$0.30$0.33$446.36 million$442.00 millionViewN/AView Earnings Details
8/2/2012$0.30$0.32ViewN/AView Earnings Details
5/2/2012$0.27$0.30ViewN/AView Earnings Details
2/9/2012$0.21$0.27ViewN/AView Earnings Details
11/3/2011$0.20$0.31ViewN/AView Earnings Details
8/4/2011$0.20$0.32ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/24/2011$0.17$0.16ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PharMerica Corp. (NYSE:PMC)
Current Year EPS Consensus Estimate: $2.01 EPS
Next Year EPS Consensus Estimate: $2.26 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.36$0.48$0.41
Q2 20162$0.37$0.46$0.42
Q3 20162$0.49$0.50$0.50
Q4 20162$0.54$0.54$0.54
Q1 20171$0.51$0.51$0.51
Q2 20171$0.55$0.55$0.55
Q3 20171$0.58$0.58$0.58
Q4 20171$0.61$0.61$0.61
(Data provided by Zacks Investment Research)

Dividends

Dividend History for PharMerica Corp. (NYSE:PMC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for PharMerica Corp. (NYSE:PMC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2015Robert A MckaySVPSell2,993$34.42$103,019.06View SEC Filing  
11/11/2015Mark LindemoenSVPSell3,790$34.71$131,550.90View SEC Filing  
6/16/2015Robert A MckaySVPSell7,000$32.75$229,250.00View SEC Filing  
6/3/2015Gregory S WeisharCEOSell104,150$32.63$3,398,414.50View SEC Filing  
6/1/2015Mark LindemoenSVPSell4,500$33.27$149,715.00View SEC Filing  
3/12/2015Berard TomassettiCAOSell3,344$26.44$88,415.36View SEC Filing  
3/12/2015Thomas A CanerisSVPSell7,495$26.52$198,767.40View SEC Filing  
3/6/2015Robert A MckaySVPSell20,000$26.74$534,800.00View SEC Filing  
8/8/2014Robert A OakleyDirectorSell8,399$26.55$222,993.45View SEC Filing  
5/13/2014Thomas CanerisSVPSell12,192$28.60$348,691.20View SEC Filing  
3/14/2014Gregory WeisharCEOSell60,000$26.27$1,576,200.00View SEC Filing  
3/13/2014Robert MckaySVPSell18,646$26.08$486,287.68View SEC Filing  
3/12/2014Berard TomassettiCAOSell3,812$25.22$96,138.64View SEC Filing  
3/6/2014Thomas CanerisSVPSell14,357$25.60$367,539.20View SEC Filing  
11/22/2013Thomas GerrityDirectorSell3,271$20.56$67,251.76View SEC Filing  
11/15/2013Berard TomassettiCAOSell4,097$20.55$84,193.35View SEC Filing  
5/30/2013Berard TomassettiCAOSell9,724$15.68$152,472.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PharMerica Corp. (NYSE:PMC)
DateHeadline
bizjournals.com logoWhat can Pharmerica do to get buyers to swipe right? (NYSE:PMC)
www.bizjournals.com - August 30 at 6:46 PM
capitalcube.com logoPharMerica Corp.: Strong price momentum but will it sustain? (NYSE:PMC)
www.capitalcube.com - August 25 at 6:59 PM
capitalcube.com logoPharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : August 25, 2016 (NYSE:PMC)
www.capitalcube.com - August 25 at 11:58 AM
fool.com logoWhy PharMerica Soared 13.4% Today (NYSE:PMC)
www.fool.com - August 24 at 9:16 PM
mysmartrend.com logoPharMerica Rises 14.24% on Heavy Volume: Watch For Potential Pullback (NYSE:PMC)
www.mysmartrend.com - August 24 at 6:37 PM
News IconPharMerica Exploring Strategic Alternatives, Including Sale -Reuters (NYSE:PMC)
ih.advfn.com - August 24 at 6:37 PM
feeds.benzinga.com logoMid-Afternoon Market Update: Crude Oil Down 2.8%; PharMerica Shares Spike Higher (NYSE:PMC)
feeds.benzinga.com - August 24 at 3:45 PM
feeds.reuters.com logoUPDATE 1-Pharmacy manager PharMerica explores possible sale -sources (NYSE:PMC)
feeds.reuters.com - August 24 at 1:20 PM
feeds.reuters.com logoSpecialty pharmacy PharMerica explores possible sale: sources (NYSE:PMC)
feeds.reuters.com - August 24 at 11:27 AM
feeds.reuters.com logoSpecialty pharmacy PharMerica explores possible sale -sources (NYSE:PMC)
feeds.reuters.com - August 24 at 11:27 AM
News IconClearspring seeks to sell Medical Pharmacies, could fetch $1 bln: Reuters (NYSE:PMC)
www.pehub.com - August 23 at 6:58 PM
capitalcube.com logoETF’s with exposure to PharMerica Corp. : August 23, 2016 (NYSE:PMC)
www.capitalcube.com - August 23 at 6:58 PM
finance.yahoo.com logoPHARMERICA CORP Financials (NYSE:PMC)
finance.yahoo.com - August 18 at 7:01 PM
News IconPharMerica Joins DC-Based Senior Care Pharmacy Coalition (SCPC) Citing Need for Effective, Focused Advocacy on Long Term Care (LTC) Pharmacy Issues (NYSE:PMC)
www.medindia.net - August 16 at 6:59 PM
publicnow.com logoPeloton Acquires Independence Valley Project, Elko County, Nevada (NYSE:PMC)
www.publicnow.com - August 16 at 6:59 PM
capitalcube.com logoPharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NYSE:PMC)
www.capitalcube.com - August 12 at 6:59 PM
capitalcube.com logoETF’s with exposure to PharMerica Corp. : August 11, 2016 (NYSE:PMC)
www.capitalcube.com - August 11 at 7:22 PM
biz.yahoo.com logoPHARMERICA CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Principal (NYSE:PMC)
biz.yahoo.com - August 10 at 7:19 PM
capitalcube.com logoPharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : August 10, 2016 (NYSE:PMC)
www.capitalcube.com - August 10 at 9:58 AM
seekingalpha.com logoPharMerica's (PMC) CEO Greg Weishar on Q2 2016 Results - Earnings Call Transcript (NYSE:PMC)
seekingalpha.com - August 9 at 7:08 PM
bizjournals.com logoOne of Pharmerica's top execs plans to retire (NYSE:PMC)
www.bizjournals.com - August 9 at 7:08 PM
twst.com logoPharMerica Corporation: PharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr. (NYSE:PMC)
www.twst.com - August 9 at 10:03 AM
sg.finance.yahoo.com logoPharMerica meets 2Q profit forecasts (NYSE:PMC)
sg.finance.yahoo.com - August 9 at 10:03 AM
publicnow.com logoPharMerica Reports Second Quarter 2016 Results (NYSE:PMC)
www.publicnow.com - August 9 at 10:03 AM
publicnow.com logoPharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr. (NYSE:PMC)
www.publicnow.com - August 9 at 10:03 AM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Intrexon, PharMerica, Surgery Partners, Civitas Solutions and Healthways (NYSE:PMC)
finance.yahoo.com - August 9 at 10:03 AM
biz.yahoo.com logoPharMerica Corp Earnings Call scheduled for 10:00 am ET today (NYSE:PMC)
biz.yahoo.com - August 9 at 10:03 AM
publicnow.com logoPeloton Completes Private Placement Financing (NYSE:PMC)
www.publicnow.com - August 6 at 9:40 AM
publicnow.com logoPeloton Completes Airborne Hyperspectral Imaging Survey Over Golden Trial Project, Nevada (NYSE:PMC)
www.publicnow.com - July 28 at 11:28 AM
capitalcube.com logoPharMerica Corp. – Value Analysis (NYSE:PMC) : July 18, 2016 (NYSE:PMC)
www.capitalcube.com - July 18 at 4:10 PM
4-traders.com logoPharMerica Corporation : Announces Second Quarter 2016 Earnings Call and Webcast (NYSE:PMC)
www.4-traders.com - July 16 at 10:08 AM
publicnow.com logoPharMerica Corporation Announces Second Quarter 2016 Earnings Call and Webcast (NYSE:PMC)
www.publicnow.com - July 14 at 4:48 PM
News IconShare Valuation Recap for: PharMerica Corporation (NYSE:PMC) - Telanagana Press (NYSE:PMC)
telanaganapress.com - July 11 at 6:51 PM
News IconStock on the Rise for the Quarter: PharMerica Corporation (NYSE:PMC) - Engelwood Daily (NYSE:PMC)
www.engelwooddaily.com - July 11 at 11:31 AM
News IconStock Rating Watch and Earnings Insight for Pharmerica Corporation (NYSE:PMC) - Press Telegraph (NYSE:PMC)
presstelegraph.com - July 11 at 11:31 AM
News IconStock Performance Rundown on: PharMerica Corporation (NYSE:PMC) - Press Telegraph (NYSE:PMC)
presstelegraph.com - July 11 at 11:31 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For Pharmerica Corporation (NYSE:PMC) - Fiscal Standard (NYSE:PMC)
www.fiscalstandard.com - July 11 at 11:31 AM
capitalcube.com logoPharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : July 11, 2016 (NYSE:PMC)
www.capitalcube.com - July 11 at 9:29 AM
News IconPharmerica Corporation (NYSE:PMC) Shorted Shares Decreased By 6.21% - Engelwood Daily (NYSE:PMC)
www.engelwooddaily.com - July 7 at 6:54 PM
News IconStock Tracking Down This Month; Investor Alert on PharMerica Corporation (NYSE:PMC) - Engelwood Daily (NYSE:PMC)
www.engelwooddaily.com - July 6 at 11:31 AM
News IconCan Pharmerica Corporation (NYSE:PMC) Improve on the Earnings Front? - Engelwood Daily (NYSE:PMC)
www.engelwooddaily.com - July 5 at 6:36 PM
News IconPharmerica Corp Stock Decreased as Institutional Investors Enter - Engelwood Daily (NYSE:PMC)
www.engelwooddaily.com - July 5 at 6:36 PM
News IconShare Performance Recap for: PharMerica Corporation (NYSE:PMC) - Press Telegraph (NYSE:PMC)
presstelegraph.com - July 5 at 6:36 PM
fiscalstandard.com logoPharmerica Corporation (NYSE:PMC) Broker Price Targets For The Coming Week - Fiscal Standard (NYSE:PMC)
www.fiscalstandard.com - July 5 at 6:36 PM
News IconCompany Stock Focus for Pharmerica Corporation (NYSE:PMC): Which Way Will Shares Head? - Press Telegraph (NYSE:PMC)
presstelegraph.com - July 5 at 6:36 PM
News IconHow Many PharMerica Corporation (NYSE:PMC)'s Analysts Are Bearish? - Press Telegraph (NYSE:PMC)
presstelegraph.com - July 2 at 6:30 PM
News IconCovering the Bases on Pharmerica Corporation (NYSE:PMC): Where is the Stock Going? - Press Telegraph (NYSE:PMC)
presstelegraph.com - July 1 at 9:37 AM
ftsenews.co.uk logoNew Broker Ratings For Pharmerica Corporation (NYSE:PMC) - FTSE News (NYSE:PMC)
www.ftsenews.co.uk - July 1 at 9:37 AM
News IconPharmerica Corporation (NYSE:PMC) Company Rating and Target Watch - Telanagana Press (NYSE:PMC)
telanaganapress.com - July 1 at 9:37 AM
finance.yahoo.com logo5 Stocks with Earnings Beat Potential to Buy Now (NYSE:PMC)
finance.yahoo.com - June 29 at 8:17 AM

Social

PharMerica Corp. (NYSE:PMC) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff